AIMS: Detection of risk of type 2 diabetes mellitus (T2DM) among adults with dysglycemia. METHODS: We used a nested case-cohort prospective design to estimate risk of new diabetes (diabetes treatment or FPG ≥7.0 mmol/L) among 1004 Framingham Heart Study Offspring with baseline dysglycemia [fasting plasma glucose (FPG) 5.4-6.9 mmol/L and/or 2-h post glucose load level 7.8-11.0 mmol/L]. Using clinical characteristics previously shown to predict incident T2DM, we used logistic regression to estimate odds ratios (OR), p-values for predictors, and assessment of model discrimination. RESULTS: At the end of 7 years follow-up there were 118 incident T2DM cases. In a model that included age, sex, elevated blood pressure or blood pressure treatment, lipid-lowering treatment and elevated triglycerides, we found the following additional characteristics to be independently associated with new T2DM: parental history of diabetes (OR 2.28, p=0.004); excess adiposity (BMI ≥30 kg/m(2) or waist circumference ≥101.6 cm) (OR 2.04, p=0.0005), and low HDL-C [<1.0 (men) or <1.3 mmol/L (women)] (OR 2.77, p<0.0001). The multivariable C-statistic for this model was 0.701, and with glycemic category information included, c=0.751. CONCLUSIONS: The key non-glycemic traits that predicted later T2DM in adults with dysglycemia were parental history of diabetes, excess adiposity and low HDL-C.
AIMS: Detection of risk of type 2 diabetes mellitus (T2DM) among adults with dysglycemia. METHODS: We used a nested case-cohort prospective design to estimate risk of new diabetes (diabetes treatment or FPG ≥7.0 mmol/L) among 1004 Framingham Heart Study Offspring with baseline dysglycemia [fasting plasma glucose (FPG) 5.4-6.9 mmol/L and/or 2-h post glucose load level 7.8-11.0 mmol/L]. Using clinical characteristics previously shown to predict incident T2DM, we used logistic regression to estimate odds ratios (OR), p-values for predictors, and assessment of model discrimination. RESULTS: At the end of 7 years follow-up there were 118 incident T2DM cases. In a model that included age, sex, elevated blood pressure or blood pressure treatment, lipid-lowering treatment and elevated triglycerides, we found the following additional characteristics to be independently associated with new T2DM: parental history of diabetes (OR 2.28, p=0.004); excess adiposity (BMI ≥30 kg/m(2) or waist circumference ≥101.6 cm) (OR 2.04, p=0.0005), and low HDL-C [<1.0 (men) or <1.3 mmol/L (women)] (OR 2.77, p<0.0001). The multivariable C-statistic for this model was 0.701, and with glycemic category information included, c=0.751. CONCLUSIONS: The key non-glycemic traits that predicted later T2DM in adults with dysglycemia were parental history of diabetes, excess adiposity and low HDL-C.
Authors: Maria Inês Schmidt; Bruce B Duncan; Heejung Bang; James S Pankow; Christie M Ballantyne; Sherita H Golden; Aaron R Folsom; Lloyd E Chambless Journal: Diabetes Care Date: 2005-08 Impact factor: 19.112
Authors: Alka M Kanaya; Christina L Wassel Fyr; Nathalie de Rekeneire; Ronald I Shorr; Ann V Schwartz; Bret H Goodpaster; Anne B Newman; Tamara Harris; Elizabeth Barrett-Connor Journal: Diabetes Care Date: 2005-02 Impact factor: 19.112
Authors: J Tuomilehto; J Lindström; J G Eriksson; T T Valle; H Hämäläinen; P Ilanne-Parikka; S Keinänen-Kiukaanniemi; M Laakso; A Louheranta; M Rastas; V Salminen; M Uusitupa Journal: N Engl J Med Date: 2001-05-03 Impact factor: 91.245
Authors: William C Knowler; Elizabeth Barrett-Connor; Sarah E Fowler; Richard F Hamman; John M Lachin; Elizabeth A Walker; David M Nathan Journal: N Engl J Med Date: 2002-02-07 Impact factor: 91.245
Authors: Marguerite J McNeely; Edward J Boyko; Donna L Leonetti; Steven E Kahn; Wilfred Y Fujimoto Journal: Diabetes Care Date: 2003-03 Impact factor: 19.112
Authors: Anthony J G Hanley; Ken Williams; Clicerio Gonzalez; Ralph B D'Agostino; Lynne E Wagenknecht; Michael P Stern; Steven M Haffner Journal: Diabetes Date: 2003-02 Impact factor: 9.461
Authors: Nanda Gruben; Anouk Funke; Niels J Kloosterhuis; Marijke Schreurs; Fareeba Sheedfar; Rick Havinga; Sander M Houten; Ronit Shiri-Sverdlov; Bart van de Sluis; Jan Albert Kuivenhoven; Debby P Y Koonen; Marten H Hofker Journal: J Diabetes Res Date: 2015-02-28 Impact factor: 4.011